When patients can’t access their MHT patches, they may consider switching to different formulations, such as tablets or gels.

Corewell Health said it has reversed its decision, and will start new gender-affirming therapies for transgender minors.

Corewell Health says it will resume allowing minors who are seeking gender-affirming care to start new hormone therapy ...

Corewell Health has lifted its pause on gender-affirming care for some minor patients, just days after announcing it and ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

Corewell Health reversed the decision Wednesday, saying "decisions are best made between physicians and their patients and families." ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.